3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
2
Gynecologic
2
Gastrointestinal
2
Breast
2
Sarcoma
1
Head & Neck
1
Genitourinary
1
Dermatologic
1
Conditions
Melanoma
44
Uveal Melanoma
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Lymphoma, T-Cell, Cutaneous
6
Lymphoma, Mantle-Cell
6
Lymphoma, Large B-Cell, Diffuse
6
Lymphoma, Follicular
6
Lymphoma, B-Cell, Marginal Zone
6
Lymphoma
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Hodgkin Disease
6
Lymphoma, Non-Hodgkin
5
Lymphoma, Large-Cell, Immunoblastic
5
Burkitt Lymphoma
5
Sezary Syndrome
4
Neoplasm Metastasis
4
Myelodysplastic Syndromes
4
Mycosis Fungoides
4
Leukemia, Myeloid, Chronic-Phase
4
Leukemia, Myeloid, Acute
4
Leukemia, Myeloid, Accelerated Phase
4
Leukemia
4
Waldenstrom Macroglobulinemia
3
Recurrence
3
Primary Myelofibrosis
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasms, Plasma Cell
3
Myeloproliferative Disorders
3
Multiple Myeloma
3
Lung Neoplasms
3
Interventions
pembrolizumab
24
Nivolumab
13
atezolizumab
7
Ipilimumab
6
Cyclophosphamide
6
fludarabine
5
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
aldesleukin
4
Interleukin-2
4
Biopsy
4
durvalumab
3
cemiplimab
3
Docetaxel
3
tislelizumab
2
osimertinib
2
fludarabine phosphate
2
enzalutamide
2
avelumab
2
X-Rays
2
Ritonavir
2
Radiotherapy
2
Observation
2
Methods
2
Immunoglobulin G
2
IFL protocol
2
Drug Therapy
2
zimberelimab
1
utomilumab
1
ulixertinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Cervical Neoplasms
×
sargramostim
×
Dermatologic
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled